BioNTech SE American Depositary Receipt
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.5B 260.8M 182.8M 1.2B
Cost of revenue 148.3M 76.4M 83.8M 243.5M
Gross profit 1.4B 184.4M 99M 946.5M
Operating expense
Research & development 564.8M 509.1M 525.6M 611.8M
Selling general and admin 148.5M 137.4M 120.6M 132.1M
Other operating expenses 3.4M 39M -13.1M -664.6M
Operating income 653.9M -501.1M -534.1M 867.2M
Non operating interest income
Income 100K 105.4M 122.6M -61.2M
Expense 7M 33.9M -2.2M
Other income expense -628.9M 79.1M
Pretax income 24.7M -402.7M -445.4M 301.2M
Tax provision 53.4M -16.1M -29.6M 41.7M
Net income -28.7M -386.6M -415.8M 259.5M
Basic EPS -0.1 -1.6 -1.7 1.1
Diluted EPS -0.1 -1.6 -1.7 1.1
Basic average shares 239.2M 240.4M 240.3M 240.3M
Diluted average shares 239.2M 240.4M 240.3M 240.3M
EBITDA 1.4B -344.7M -368.7M 464.4M
Net income from continuing op. 24.7M -402.7M -445.4M 301.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 10 hours 50 minutes

21:09
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).